2.43

2.53% +0.06

Invivyd Inc (IVVD)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$2.37

Aprire:

$2.37

Volume 24 ore:

417.65K

Capitalizzazione di mercato:

$289.94M

Reddito:

Utile/perdita netta:

$-198.64M

Rapporto P/E:

-1.5093

EPS:

-1.61

Flusso di cassa netto:

$-173.78M

1 W Prestazione:

-3.19%

1M Prestazione:

-17.63%

6M Prestazione:

+62.00%

1 anno Prestazione:

+68.75%

Intervallo 1D:

$2.34

$2.45

Portata 52W:

$0.9802

$5.195

Invivyd Inc Stock (IVVD) Company Profile

Nome

Invivyd Inc

Settore

Healthcare (1211)

Industria

Biotechnology (696)

Telefono

781 819 0080

Indirizzo

1601 Trapelo Road, Suite 178, Waltham

Dipendente

101

Cinguettio

Prossima data di guadagno

Ultimi documenti SEC

IVVD's Discussions on Twitter

Invivyd Inc Stock (IVVD) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-12-19	Aggiornamento	Morgan Stanley	Underweight → Equal-Weight
2023-05-01	Iniziato	H.C. Wainwright	Buy

Invivyd Inc Borsa (IVVD) Ultime notizie

Invivyd to Participate at the H.C. Wainwright 2nd Annual BioConnect Investor Conference

GlobeNewswire Inc.

Invivyd Reports First Quarter 2024 Financial Results and Recent Business Highlights

GlobeNewswire Inc.

Invivyd to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19 in Moderately to Severely Immunocompromised People, Based on U.S. FDA Feedback

GlobeNewswire Inc.

Invivyd to Host Conference Call Discussing First Quarter 2024 Financial Results and Business Highlights

GlobeNewswire Inc.

Invivyd Announces $20 Million to $25 Million Improvement in Projected 2024 Year-End Cash Position

GlobeNewswire Inc.

Invivyd Receives Healthcare Common Procedure Coding System (HCPCS) Reimbursement Codes from the U.S. Centers for Medicare & Medicaid Services (CMS) Covering PEMGARDA™

GlobeNewswire Inc.

Invivyd Inc Azioni (IVVD) Dati Finanziari

Invivyd Inc (IVVD) Reddito netto 2024

IVVD l'utile netto (TTM) è stato di -$198.64 milioni per il trimestre terminato il 2023-12-31, un +17.68% aumento anno su anno.

Invivyd Inc (IVVD) Flusso di cassa 2024

IVVD ha registrato un flusso di cassa disponibile (TTM) di -$173.78 milioni per il trimestre conclusosi con 2023-12-31, un +21.00% aumento anno su anno.

Invivyd Inc (IVVD) Utile per azione 2024

L'utile per azione (TTM) di IVVD è stato pari a -$1.81 per il trimestre terminato il 2023-12-31, un +18.83% crescita anno su anno.

BMRN

$79.65

1.06%

BGNE

$160.77

0.86%

ALNY

$147.89

1.33%

GMAB

$29.53

1.27%

ARGX

$356.01

0.97%

BNTX

$92.28

0.47%

Apri su Yahoo | Apri su Google | Aperto in Finviz

Invivyd Inc (IVVD)

Invivyd Inc Stock (IVVD) Company Profile

Invivyd Inc Stock (IVVD) Upgrades & Downgrades

Invivyd Inc Borsa (IVVD) Ultime notizie

Invivyd to Participate at the H.C. Wainwright 2nd Annual BioConnect Investor Conference

Invivyd Reports First Quarter 2024 Financial Results and Recent Business Highlights

Invivyd to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19 in Moderately to Severely Immunocompromised People, Based on U.S. FDA Feedback

Invivyd to Host Conference Call Discussing First Quarter 2024 Financial Results and Business Highlights

Invivyd Announces $20 Million to $25 Million Improvement in Projected 2024 Year-End Cash Position

Invivyd Receives Healthcare Common Procedure Coding System (HCPCS) Reimbursement Codes from the U.S. Centers for Medicare & Medicaid Services (CMS) Covering PEMGARDA™

Invivyd Inc Azioni (IVVD) Dati Finanziari

Invivyd Inc (IVVD) Reddito netto 2024

Invivyd Inc (IVVD) Flusso di cassa 2024

Invivyd Inc (IVVD) Utile per azione 2024

Simile a IVVD